Antibodies to Combat Viral Infections: Development Strategies and Progress

The authors describe advances in antibody discovery and engineering that have led to the development of monoclonal antibodies for use against infections caused by viruses including SARS-CoV-2, respiratory syncytial virus, Ebola virus, human cytomegalovirus, and influenza.